Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Phase III Study of JR-401 (somatropin) in Short Stature Patients With SHOX Deficiency
jRCT2080223889Phase 3Completed
- Sponsor
- JCR Pharmaceuticals
- Start
- Apr 2018
- Modality
- Recombinant Proteins and Enzymes
- Countries
- 1
01
Overview
Phase 3, open-label, single-arm trial of somatropin in SHOX deficiency disorder and SHOX haploinsufficiency, sponsored by JCR Pharmaceuticals. Started Apr 2018; status: completed.
02
Drugs
somatropin
03
Conditions
SHOX deficiency disorderSHOX haploinsufficiency
Beyond the preview
Go deeper on jRCT2080223889.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on jRCT2080223889.